|
⚲
|
| Keyboard |
| von Seggern Christopher
✚
|
|
|---|---|
| CIK # | 0001821192 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001821192] | |
| 4 | [0001821192] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Xenon Pharmaceuticals Inc | |
| von Seggern Christopher |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2024-03-11 | Grant | 100,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2023-03-10 | Grant | 90,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2022-03-10 | Grant | 100,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2021-12-06 | Buy | 4,000 | $24.40 | 97,600 |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2021-03-12 | Grant | 60,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2020-08-17 | Grant | 100,000 | $0.00 |